03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Urbason Forte 1g* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Benta Trading Co |
Distributor | Benta Trading Co |
Laboratory | Sanofi |
Responsible Party | Hoechst AG |
Origin | Germany |
Manufacturer | Hoechst AG |
Origin | Germany |
ATC | H02AB04 |
Urbason Forte 1g* :
Urbason Forte 1g* :
Urbason Forte 1g* :
Urbason Forte 1g* :
Urbason Forte 1g* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Urbason Forte 1g* :
Urbason Forte 1g* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Not known |
Abnormal behaviour | Common |
Abscess sterile | Not known |
Achilles tendon rupture | Not known |
Acne | Common |
Affect lability | Not known |
Alkalosis hypochloraemic | Not known |
Amnesia | Not known |
Anaphylactoid reactions | Not known |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anxiety | Not known |
Arrhythmia | Not known |
Arthralgia (Pain joint) (Joint ache) | Not known |
Benign intracranial hypertension | Not known |
Blood alkaline phosphatase increased | Not known |
Blood calcium decreased | Not known |
Blood phosphate decreased | Not known |
Cardiac arrest | Not known |
Cardiac failure | Not known |
Cephalea | Not known |
Chorioretinitis | Not known |
Cognitive disorder | Not known |
Compression fracture | Not known |
Confusional state | Not known |
Convulsion | Not known |
Cushing's syndrome | Common |
Dependence psychological | Not known |
Depressed mood | Common |
Diarrhoea (Diarrhea) | Not known |
Dyslipoproteinemia | Not known |
Dyspepsia | Not known |
Ecchymosis | Common |
Epidural lipomatosis | Not known |
Erythema | Not known |
Euphoric mood | Common |
Exophthalmos (Bulging eyes) | Not known |
Fatigue | Not known |
Fluid retention | Common |
Gastroduodenal haemorrhage | Common |
Glaucoma | Not known |
Glucose tolerance decreased | Not known |
Growth retardation | Common |
Hallucination | Not known |
Hepatic function abnormal | Not known |
Hepatitis | Not known |
Hiccups | Not known |
Hirsutism | Not known |
Hyperhidrosis | Not known |
Hypersensitivity reactions | Not known |
Hypertension | Common |
Hypokalaemia | Common |
Hypopituitarism | Not known |
Hypotension | Not known |
Impotence | Not known |
Increased appetite | Not known |
Infection | Common |
Injection site erythema | Not known |
Injection site pruritus | Not known |
Injection site rash | Not known |
Injection site urticaria | Not known |
Insomnia | Common |
Intestinal perforation | Not known |
Intracranial hypertension (Intracranial pressure increased) | Not known |
Intraocular pressure increased | Not known |
Irritability | Common |
Kaposi's sarcoma | Not known |
Leukocytosis | Not known |
Lipomatosis | Not known |
Mania | Not known |
Menstruation irregular | Not known |
Mental disorder | Not known |
Mood altered | Common |
Muscle atrophy | Not known |
Muscle weakness | Common |
Myalgia | Not known |
Myocardial rupture | Very rare |
Myopathy | Not known |
Nausea | Not known |
Neuropathic arthropathy | Not known |
Nitrogen balance negative | Not known |
Obsession | Not known |
Oedema peripheral | Common |
Oesophagitis | Not known |
Oesophagitis ulcerative | Not known |
Opportunistic infections | Not known |
Osteonecrosis | Not known |
Osteoporosis | Common |
Pancreatitis | Not known |
Papilloedema | Not known |
Pathological fracture | Not known |
Peptic ulcer | Common |
Peritonitis | Not known |
Personality disorder | Not known |
Petechiae | Not known |
Phaeochromocytoma | Not known |
Pigmentation disorder | Not known |
Posterior subcapsular cataract | Common |
Pruritus | Not known |
Psychotic disorders | Not known |
Schizophrenia | Not known |
Sensation of malaise | Not known |
Skin atrophy | Common |
Skin Eruption | Not known |
Skin striae | Not known |
Skin test abnormal | Not known |
Sodium retention | Common |
Steroid withdrawal syndrome | Not known |
Suicidal ideation | Not known |
Thromboembolic event | Not known |
Transaminases increased | Not known |
Urticaria | Not known |
Vertigo | Not known |
Vomiting | Not known |
Weight increased (weight gain) | Not known |
NB : Products With Same Indication |
Different Units By MoH Code
Urbason Forte 1g* MoH 3104 :
Form | Powder and solvent for solution for injection |
Packaging | Bottle |
Package Size | 1+1x10ml |
Strength | 1g |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 135378 |
Submission date | 01/01/1997 |
Registration Year | 1997 |
Archived Date | 2014 |
Price Comparison
You have to register to view this info
Drop File